113 related articles for article (PubMed ID: 16003553)
1. Influential factors on tumor recurrence in head and neck cancer patients.
Matthias C; Harréus U; Strange R
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):37-42. PubMed ID: 16003553
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract][Full Text] [Related]
3. [Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer].
Matthias C; Jahnke V; Fryer AA; Strange RC
Laryngorhinootologie; 2002 Jun; 81(6):406-12. PubMed ID: 12063626
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
5. [First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer].
Matthias C; Jahnke V; Fryer AA; Strange RC
Laryngorhinootologie; 2003 Jan; 82(1):25-30. PubMed ID: 12548461
[TBL] [Abstract][Full Text] [Related]
6. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
7. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
[TBL] [Abstract][Full Text] [Related]
8. [Genetic predisposition for the development of head and neck carcinomas].
Jahnke V; Matthias C; Bockmühl U; Strange RC
Laryngorhinootologie; 1999 Jan; 78(1):24-7. PubMed ID: 10080124
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
[TBL] [Abstract][Full Text] [Related]
10. TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.
Zhang C; Sturgis EM; Zheng H; Zafereo ME; Wei Q; Li G
Int J Cancer; 2014 Oct; 135(7):1615-24. PubMed ID: 24550071
[TBL] [Abstract][Full Text] [Related]
11. [Effect of gene polymorphism on detoxifying glutathione-S-transferase enzymes on chromosomal stability of squamous epithelial carcinomas in the area of the head-neck].
Matthias C; Bockmühl U; Jahnke V; Petersen I; Dietel M; Fryer A; Strange RC
Laryngorhinootologie; 1998 Apr; 77(4):201-6. PubMed ID: 9592753
[TBL] [Abstract][Full Text] [Related]
12. [Influence of genetic variation in the major histocompatibility complex on head and neck cancer susceptibility].
Matthias C; Jahnke V; Hajeer A; Ollier W; Fryer AA; Strange RC
Laryngorhinootologie; 2001 Oct; 80(10):595-600. PubMed ID: 11602932
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.
Fan CY
Curr Oncol Rep; 2001 Jan; 3(1):66-71. PubMed ID: 11123872
[TBL] [Abstract][Full Text] [Related]
14. [Initial results of glutathione-S-transferase GSTM1 and GSTT1 genotypes and genetic predisposition for laryngeal carcinoma].
Jahnke V; Strange R; Matthias C; Fryer AA
Laryngorhinootologie; 1995 Nov; 74(11):691-4. PubMed ID: 8561822
[TBL] [Abstract][Full Text] [Related]
15. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
19. GSTM1 and GSTT1 genes analysis in head and neck cancer patients.
Leme CV; Raposo LS; Ruiz MT; Biselli JM; Galbiatti AL; Maniglia JV; Pavarino-Bertelli EC; Goloni-Bertollo EM
Rev Assoc Med Bras (1992); 2010; 56(3):299-303. PubMed ID: 20676536
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
